patients undergoing distal pancreatectomy
Conditions
Interventions
1)The pancreas transection are performed using the Endoscopic linear Cutter Echelon 60TM (EC60A), green cartridge (ECR60G).The closure jaw of the staple are clamped carefully and slowly at a fixed spe
Sponsors
Multicenter Clinical Study Group of Osaka
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The distal pancreatectomy cases against pancreatic tail region diseases, including inflammatory diseases, such as tumor-forming pancreatitis. 2) the presence or absence of the presence or absence spleen preservation of vascular resection does not matter. 3) Cases we planed to use a patch of PGA felt as pancreatic stump treatment. 4) Preoperative ECOG of Performance Status (PS) is 0-1. 5) Older than 20 years old 6) Cases that do not recognize the obvious distant metastases at inspection. 7) Major organ function is preserved. Patients meet all of the following in the 14 days prior and subsequent inspection of the registration date. 1. white blood cell (WBC): 2,000 / mm3 < WBC <12,000 / mm3 2. neutrophil count (Neut): Neut > 1,000 / mm3 3. hemoglobin (Hb): Hb > 9.0 g / dL 4. platelet count (Plt): Plt > 80,000 / mm3 5. serum total bilirubin (TB): TB < 2.0 mg / dL 6. serum AST: AST < 150 IU / L 7. serum ALT: ALT < 150 IU / L 8. serum creatinine (Cr): Cr < 1.5mg / dL 9. serum albumin (Alb): Alb > 2.5 g / dL 8) consent from patients have been obtained in writing.
Exclusion criteria
Exclusion criteria: 1) Patients with a history of hypersensitivity to components of PGA felt. 2) Cases with serious complications such as heart disease and kidney disease. 3) Drug abusers, mentally unstable patients, and patients judged difficult to communicate with physicians. 4) Pregnant women or women who may possibly be pregnant. 5) Patients undergoing treatment with aprotinin, procoagulant and anti-thrombolytic agents are excluded because there is a possibility that appears thrombophilia may occur by using a tissue adhesive. 6) Patient judged inadguate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The frequency of occurrence of pancreatic fistula | — |
Secondary
| Measure | Time frame |
|---|---|
| morbidity, mortality, postoperative hospital stay and the incidence of late pancreatic pseudocyst | — |
Countries
Japan
Contacts
Public ContactHidetoshi Eguchi
Osaka University, Graduate School of Medicine Department of Gastroenterological Surgery
Outcome results
None listed